Global HIV Funding Retreat Fuels New Surge
2026-07-29
Global HIV funding is retreating just when the virus had been cornered. A collapse in overseas aid from the US and several European governments has pushed international resources for HIV prevention and treatment to the lowest level seen in about two decades, according to major donor and UN tracking data, reversing years of incremental progress against the epidemic.
This rollback is not a budget tweak; it is a structural blow. As pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria and to bilateral programs shrink in real terms, national health ministries are forced to thin out antiretroviral therapy coverage and scale back pre‑exposure prophylaxis campaigns, undermining viral suppression and basic epidemiological control in countries that rely on external financing for more than half of their HIV response.
The uncomfortable truth is that donor fatigue is now rewriting the epidemiology of HIV. With fewer outreach workers, disrupted supply chains for diagnostic testing, and stagnant investment in harm‑reduction services for key populations, surveillance teams report early signs of rising new infections and preventable deaths, a reversal that exposes how dependent the supposed success story always was on sustained funding from a small circle of wealthy states.
Loading...
